Stocks and Investing
Stocks and Investing
Wed, August 5, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 4, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $168 on, Aug 4th, 2015
Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $163 to $168 on, Aug 4th, 2015.
Christopher has made no other calls on BMRN in the last 4 months.
There are 5 other peers that have a rating on BMRN. Out of the 5 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Christopher
- Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $156 on, Thursday, June 18th, 2015
- Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $151 on, Thursday, June 18th, 2015
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $156 on, Thursday, June 18th, 2015
- Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $145 on, Thursday, June 18th, 2015
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Thursday, June 18th, 2015